Neurotrophic factors are required by mature sympathetic neurons for survival, transmission and connectivity

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 8, 1997, Pages 549-555

  Rush, Robert A ^a   Chie, Edward ^a   Liu, Dennis ^a   Tafreshi, Azita ^a   Zettler, Christian ^a   Zhou, Xin Fu ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Nerve growth factor; Neuronal survival; Neurotrophin 3; Sympathetic nerve function; Sympathetic neurons

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN 3;

ADRENERGIC SYSTEM; ANIMAL TISSUE; CELL MATURATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; NERVE FUNCTION; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVE INJURY; POSTNATAL DEVELOPMENT; RAT; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030751436     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02089.x     Document Type: Review

References (31)

1. Watson A. President's address: The study of anatomy and physiology. In: Proceedings of the 4th Session of the Intercolonial Medical Congress of Australasia. Dunedin: The Otago Daily Times and Witness Newspapers Co. Ltd., 1896; pp. 356-7.
2. Harrison RG. Observations on the living developing nerve fibre. Anat. Rec. 1907; 1: 116-18.
3. Harrison RG. The outgrowth of the nerve fibre as a mode of protoplasmic movement. J. Exp. Zool. 1910; 9: 787-846.
4. Levi-Montalcini R. Nerve growth factor: 35 years later. Science 1987; 237: 1154-62.
5. Hendry IA, Stockel K. Thoenen H, Iversen LL. The retrograde axonal transport of nerve growth factor. Brain Res. 1974; 68: 103-21.
6. Segal RA, Greenberg ME. Intracellular signalling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 1996; 19: 463-89.
7. Donahue SJ, Stitzel RE, Head RJ. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats. J. Pharmacol. Exp. Ther. 1987; 245: 24-31.
8. Ueyama T, Hamada M, Hano T, Nisho I Masuyama Y, Furukawa S. Nerve growth factor is increased in spontaneously hypertensive rats. J. Hypertens. 1992; 10: 215-19.
9. Zettler C, Zhou X-F, Bridges D, Rush RA. Increased concentrations of nerve growth factor detected in tissue extracts with an improved extraction procedure. J. Neurosci. Res. 1996; 46: 581-94.
10. Rush RA, Mayo R, Zettler C. The regulation of nerve growth factor synthesis and delivery to peripheral neurons. Pharmacol. Ther. 1995; 65: 93-123.
11. Ueyama T, Hamada M, Hano TN, Masuyama Y. New role of nerve growth factor: An inhibitory neuromodulator of adrenergic transmission. Brain Res. 1991; 559: 293-6.
12. Liu DT, Reid MT, Bridges DMcL, Rush RA. Denervation, but not decentralization, reduces nerve growth factor content of the mesenteric artery. J. Neurochem. 1996; 66: 2295-9.
13. Lees GJ, Chubb IW, Freeman C, Geffen LB, Rush RA. Effect of nerve activity on transport of nerve growth factor and dopamine-beta-hydroxylase antibodies in sympathetic neurons. Brain Res. 1981; 214: 186-9.
14. Lee RMKW, Triggle GR, Cheung DWT, Coughlin MD. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension 1987; 10: 328-38.
15. Zettler C, Rush RA. Elevated concentrations of nerve growth factor in heart and mesenteric arteries of spontaneously hypertensive rats. Brain Res. 1993; 614: 15-20.
16. Brock JA, Van Helden DF, Dosen P, Rush RA. Prevention of high blood pressure by reducing sympathetic innervation in the SHR. J. Auton. Nerv. Syst. 1996; 61: 97-102.
17. Zettler C, Head RJ, Rush RA. Chronic nerve growth factor treatment of normotensive rats. Brain Res. 1991; 538: 251-62.
18. Jeffreson S, Rush RA, Zettler C, Frewin DB, Head RJ. The influence of the renin-angiotensin system on abnormal expression of nerve growth factor in the spontaneously hypertensive rat. Clin. Exp. Pharmacol. Physiol. 1995; 22: 478-80.
19. Hohn A, Leibrock J, Bailey K, Barde Y-A. Identification and characterization of a novel member of the nerve growth factor/brain derived neurotrophic factor family. Nature 1990; 344: 339-41.
20. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 1994; 369: 658-61.
21. Verdi JM, Groves AK, Farinas I et al. A reciprocal cell-cell interaction mediated by NT-3 and neuregulin controls the early survival and development of sympathetic neuroblasts. Neuron 1996; 16: 515-27.
22. Chalazonitis A. Neurotrophin-3 as an essential signal for the developing nervous system. Mol. Neurobiol. 1996; 12: 39-53.
23. Zhou X-F, Rush RA. Functional roles of neurotrophin 3 in the developing and mature sympathetic nervous system. Mol. Neurobiol. 1996; 13: 185-97.
24. Tafreshi PA, Zhou X-F, Rush RA. Endogenous neurotrophin 3 regulates trkC and trkA phosphorylation in mature sympathetic neurons and mesenteric vessels. Proc. Aust. Neurosci. Soc. 1997; 8: O8-1.
25. Zhou X-F, Rush RA. Sympathetic neurons in neonatal rats require endogenous neurotrophin 3 for survival. J. Neurosci. 1995; 15: 6521-30.
26. Tafreshi PA, Zhou X-F, Rush RA. Endogenous nerve growth factor and neurotrophin 3 act simultaneously to ensure the survival of postnatal sympathetic neurons. Proc. Aust. Neurosci. Soc. 1996; 7: O17-2.
27. McLachlan EM, Janig W, Devor M, Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglion. Nature 1993; 363: 543-6.
28. Rush RA. Immunohistochemical localization of endogenous nerve growth factor. Nature; 312: 364-7.
29. Johnson EM Jr, Tanuchi M, DiStefano PS. Expression and possible function of nerve growth factor receptor on Schwann cells. Trends Neurosci. 1988; 11: 299-304.
30. Zhou X-F, Rush RA. Endogenous nerve growth factor is required for regulation of the low affinity neurotrophin receptor (p75) in sympathetic but not sensory ganglia. J. Comp. Neurol. 1996; 372: 37-48.
31. Zhou X-F, Rush RA, McLachlan EM. Differential expression of p75 nerve growth factor receptor by glia and neurons in the dorsal root ganglia following peripheral nerve injury. J. Neurosci. 1996; 16: 2901-11.